Womens Imaging: Page 37

CEM has tradeoffs for imaging extremely dense breasts
By Amerigo Allegretto
Contrast-enhanced mammography (CEM) has tradeoffs when it comes to imaging women with extremely dense breasts.
October 1, 2024
2024 10 01 Radiology Cem Thumbnail
ACS: Breast cancer mortality decreases, disparities persist
By Amerigo Allegretto
A new ACS report found that although overall breast cancer mortality continues to decline, racial and ethnic disparities persist.
October 1, 2024
Breast Mammo 400
Publicly insured pregnant women less likely to get 20-week ultrasounds
By Amerigo Allegretto
Twenty-week ultrasound exams for pregnant women drives disparities in prenatal diagnosis of congenital heart defects.
September 23, 2024
Fetal Ultrasound
CEM-guided biopsy not a good substitute for breast MRI
By Amerigo Allegretto
Contrast-enhanced mammography (CEM)-guided biopsy by itself is not a good substitute for MRI-guided biopsy of suspicious breast MRI findings.
September 18, 2024
Breast Cancer3
Black women at higher risk of breast cancer death across all subtypes
By Amerigo Allegretto
Black women have a higher risk of dying from breast cancer across all tumor subtypes compared with white women.
September 18, 2024
Black Women Hands Mammography
DBT increases cancer detection over 10-year period
By Amerigo Allegretto
Digital breast tomosynthesis (DBT) increased breast cancer detection rates in a 10-year analysis.
September 17, 2024
Images depict a 67-year-old woman who was recalled from screening for a small focal asymmetry in the left breast. (A) 2D mammographic image shows the lesion (arrow), which is difficult to see. (B) The digital breast tomosynthesis section image shows spiculated margins (circle). (C) The ultrasound image shows a corresponding irregular hypoechoic mass with angular margins. Pathologic evaluation revealed a 0.7-cm triple-negative invasive carcinoma. Image courtesy of RSNA.
Social-environmental injustice impacts cancer screening rates
By Amerigo Allegretto
Areas with high levels of social-environmental injustice experience lower rates of cancer screening.
September 16, 2024
Mammogram Calendar 400
Breast arterial calcifications tied to heart disease in women
By Amerigo Allegretto
Breast arterial calcifications as seen on mammograms may be a warning sign of heart disease in women.
September 11, 2024
Breast Mammo
Advocates, researchers herald federal breast density notification law
By Amerigo Allegretto
September 10 marks a big day in breast health as the federal mandate on breast density notification takes effect.
September 10, 2024
Capitol Hill2
F-18 FAPI PET/CT upstages more newly-diagnosed breast cancers
By Amerigo Allegretto
F-18 FAPI PET/CT leads to significant upstaging in newly diagnosed breast cancer compared with F-18 FDG.
September 6, 2024
Breast Cancer Cell2 Social
MRI model predicts treatment response in breast cancer patients
By Amerigo Allegretto
Radiomics scoring derived from contrast-enhanced MRI can predict treatment response in women being treated for triple-negative breast cancer.
September 3, 2024
Axial dynamic contrast-enhanced MRI scans show results from two women before they underwent neoadjuvant chemoimmunotherapy for triple-negative breast cancer. (A) T1-enhanced MRI scan, (B) rate constant for contrast agent plasma-to-interstitial transfer (Ktrans) map, and (C) maximum contrast agent uptake rate (Slopemax) map in a 56-year-old woman depict a tumor that manifested as a spherical 4-cm mass enhancement (arrow in A) in the right breast with axillary node involvement (arrowhead in A). The radiomics score was high, at 3.3. Histopathologic examination after chemotherapy revealed no invasive residual cancer in the breast or the lymph nodes (pathologic complete response). (D) T1-enhanced MRI scan, (E) Ktrans map, and (F) Slopemax map in a 49-year-old woman show a tumor that manifested as a spiculated 3-cm mass enhancement (arrow in D) in the left breast with thickening of the skin (arrowhead in D). The parametric maps show much greater spatial heterogeneity than in the case shown in B and C, with areas of high intensity. The radiomics score was low, at −1.6. Histopathologic examination after chemotherapy revealed a 10-mm invasive residual cancer in the breast (not pathologic complete response). Image courtesy of the RSNA.
Women less likely to return to mammo after false-positive results
By Amerigo Allegretto
Women are less likely to return to screening after false-positive mammography results.
September 3, 2024
Breast Mammography Scanner
Previous Page
Page 37 of 713
Next Page